| |SEPTEMBER 2026710 GLP-1 Drugs Revolutionizing Diabetes & Obesity Treatment10ANALYSIS12THOUGHT CENTRALWhy Peptides and Complex Generics Will Define India Pharma's FutureSaurabh Agarwal,Director,HAB Pharmaceuticals and Research Pharmaceuticals & Biotech203026How Biologics and Complex Therapies Are Reshaping CDMO StrategyDriving Vaccine Adoption Beyond Pediatric Immunization in IndiaTransforming API & Pharma Manufacturing with Next-Gen EHS TechnologiesAkhil Ravi,CEO,Aurigene Pharmaceutical Services LimitedNilesh Pendse, Director - Vaccines, Pfizer IndiaDr Kuber Jagdale, President - API Business Unit, Emcure Pharmaceutical Business FormationVIVID OUTLOOKTOP STORIES0809AFTERWORDIndia's Hospitals Risk Falling into the U.S.-Style Fee-for-Service TrapViren Shetty,Executive Vice Chairman, Narayana Health 34C ONTE NT S2428--TOXREMEDIESWILWIN LABORATORIESPharma Toxicology Consultant For The YearPharma Antibiotics Contract Manufacturer For The Year
< Page 6 | Page 8 >